Ogilvie's Syndrome - is there a right therapy?

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00024464

Enrollment

Registered

2021-02-09

Start date

2020-06-21

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

K56.0

Interventions

Group 1: In this study, patients with Ogilvie's syndrome are retrospectively evaluated regarding the treatment they received (conservative, endoscopic, surgical) and the therapeutic succes. In this co

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: all patients who were treated for Ogilvie's Syndrome between 2002 and 2019 at the University Medical Center Freiburg, Germany, Department for General and Viszeral Surgery

Exclusion criteria

Exclusion criteria: age less than 18 years

Design outcomes

Primary

Measure	Time frame
Primary endpoint of this study is therapeutic success which is examined in a time frame of 7 days after initiation of treatment by clinical presentation of the patients, bowel movement and lab results (CRP, leukocytes, lactat).	—

Secondary

Measure	Time frame
morbidity, longterm outcome	—

Countries

Germany

Contacts

Public ContactLampros Kousoulas

Universitätsklinikum Freiburg, Departemnt Chirurgie, Klinik für Allgemein- und Viszeralchirurgie

lampros.kousoulas@uniklinik-freiburg.de076127024010

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026